Primary signet-ring cell carcinoma of the urinary bladder
Nirmalya Benerjee; Kalpesh Parmar; Kim Vaiphei
Abstract
Keywords
References
1 Saphir O. Signet-ring cell carcinoma of the urinary bladder. Am J Pathol. 1955;31(2):223-31. PMid:14350063.
2 Lendorf ME, Dohn LH, Dunga BA, Loya AC, Pappot H. An updated review on primary signet-ring cell carcinoma of the urinary bladder and report of a case. Scand J Urol. 2018;52(2):87-93.
3 Wang J, Wang FW. Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder. Urol Int. 2011;86(4):453-60.
4 Nath V, Baliga M. Urinary bladder adenocarcinoma metastatic to the abdominal wall: report of a case with cytohistologic correlation. Case Rep Pathol. 2016;2016:8608412.
5 Wang J, Wang F, Kessinger A. The impact of signet-ring cell carcinoma histology on bladder cancer outcome. World J Urol. 2012;30(6):777-83.
6 Paner GP, Lopez-Beltran A, Sirohi D, Amin MB. Updates in the pathologic diagnosis and classification of epithelial neoplasms of urachal origin. Adv Anat Pathol. 2016;23(2):71-83.
7 Yamamoto S, Ito T, Akiyama A, et al. Primary signet‐ring cell carcinoma of the urinary bladder inducing renal failure. Int J Urol. 2001;8(4):190-3.
8 Akamatsu S, Takahashi A, Ito M, Ogura K. Primary signet-ring cell carcinoma of the urinary bladder. Urology. 2010;75(3):615-8.
9 Blute ML, Segura JW, Patterson DE, Benson RC Jr, Zincke H. Impact of endourology on diagnosis and management of upper urinary tract urothelial cancer. J Urol. 1989;141(6):1298-301.
10 Fiter L, Gimeno F, Martin L, Gómez Tejeda L. Signet-ring cell adenocarcinoma of bladder. Urology. 1993;41(1):30-3.
11 Harik LR, O’Toole KM. Nonneoplastic lesions of the prostate and bladder. Arch Pathol Lab Med. 2012;136(7):721-34.
12 Hirano Y, Suzuki K, Fujita K, et al. Primary signet-ring cell carcinoma of the urinary bladder successfully treated with intra-arterial chemotherapy alone. Urology. 2002;59(4):601.
13 Guan H, Tatsas AD, Ali SZ. Signet ring cell carcinoma in urine cytology: cytomorphologic findings and differential diagnosis. Acta Cytol. 2012;56(2):177-82.
14 Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol. 2009;40(1):108-16.
15 Fritsche HM, Burger M, Denzinger S, Legal W, Goebell PJ, Hartmann A. Plasmacytoid urothelial carcinoma of the bladder: histologic and clinical features of 5 cases. J Urol. 2008;180(5):1923-7.
16 Amin MB, Smith SC, Eble JN, et al. Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification. Am J Surg Pathol. 2014;38(8):1033-45.
17 Verma A, Tomar V. Signet ring cell carcinoma of urachal origin presenting as irritative lower urinary tract symptoms and pain abdomen: a rare case report. J Clin Diagn Res. 2016;10(7):PD12-3.
18 Egevad L, Håkansson U, Grabe M, Ehrnström R. Urachal signet-cell adenocarcinoma. Scand J Urol Nephrol. 2009;43(1):88-91.
19 Pugashetti N, Yap SA, Lara PN Jr, Gandour-Edwards R, Dall’Era MA. Metastatic signet-ring cell carcinoma of the urinary bladder: a novel management approach to a rare tumor. Cuaj. 2015;9(3-4):E204-7.
20 Erdoğru T, Kilicaslan I, Esen T, Ander H, Ziylan O, Uysal V. Primary signet-ring cell carcinoma of the urinary bladder: review of the literature and report of two cases. Urol Int. 1995;55(1):34-7.
21 El Ammari JE, Ahsaini M, Riyach OEI, et al. Primary signet-ring cell carcinoma of the urinary bladder successfully managed with cisplatin and gemcitabine: a case report. J Med Case Rep. 2013;7(1):37.
Submitted date:
09/08/2020
Accepted date:
02/11/2021
Publication date:
04/22/2021